Nifty
:
23907.25
Sensex
:
79117.11
557.35 (2.39%)
1961.32 (2.54%)
Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Apollo Hospitals Enterprise Ltd.

Hospital & Healthcare Services

Rating :
N/A

BSE: 508869 | NSE: APOLLOHOSP

NSE BSE
6328.55
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  6201.00
  •  6342.85
  •  6159.00
  •  6225.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  350300
  •  22007.32
  •  7545.00
  •  5284.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 98,191.26
  • 82.99
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,00,829.46
  • 0.23%
  • 13.10

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.33%
  • 0.26%
  • 3.62%
  • FII
  • DII
  • Others
  • 45.37%
  • 18.93%
  • 2.49%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.92
  • 11.13
  • 9.14

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.52
  • 8.62
  • 1.81

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.29
  • 13.97
  • -5.65

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 86.77
  • 89.83
  • 86.20

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.75
  • 10.95
  • 11.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.18
  • 32.61
  • 33.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
5,589.30
4,846.90
15.32%
5,085.60
4,417.80
15.12%
4,943.90
4,302.20
14.92%
4,850.60
4,263.60
13.77%
Expenses
4,773.80
4,219.40
13.14%
4,410.50
3,908.80
12.84%
4,303.40
3,814.10
12.83%
4,236.90
3,758.20
12.74%
EBITDA
815.50
627.50
29.96%
675.10
509.00
32.63%
640.50
488.10
31.22%
613.70
505.40
21.43%
EBIDTM
14.59%
12.95%
13.27%
11.52%
12.96%
11.35%
12.65%
11.85%
Other Income
38.20
22.20
72.07%
37.20
28.20
31.91%
28.10
16.40
71.34%
27.80
35.40
-21.47%
Interest
117.50
111.30
5.57%
116.40
106.20
9.60%
119.30
95.40
25.05%
112.60
100.00
12.60%
Depreciation
184.50
163.40
12.91%
177.40
166.90
6.29%
189.70
159.10
19.23%
167.00
153.40
8.87%
PBT
551.70
376.90
46.38%
418.50
264.10
58.46%
359.60
250.00
43.84%
361.90
287.40
25.92%
Tax
161.70
130.20
24.19%
114.50
96.60
18.53%
109.80
108.00
1.67%
108.90
103.50
5.22%
PAT
390.00
246.70
58.09%
304.00
167.50
81.49%
249.80
142.00
75.92%
253.00
183.90
37.57%
PATM
6.98%
5.09%
5.98%
3.79%
5.05%
3.30%
5.22%
4.31%
EPS
26.34
16.20
62.59%
21.23
11.59
83.18%
17.65
10.05
75.62%
17.06
10.68
59.74%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
20,469.40
19,059.20
16,612.50
14,662.60
10,560.00
11,246.80
9,617.40
8,243.47
7,255.70
6,214.65
5,178.45
Net Sales Growth
14.80%
14.73%
13.30%
38.85%
-6.11%
16.94%
16.67%
13.61%
16.75%
20.01%
 
Cost Of Goods Sold
10,559.50
9,805.50
8,574.30
7,573.50
5,684.20
5,498.90
4,660.90
4,032.66
3,598.88
3,054.74
2,581.20
Gross Profit
9,909.90
9,253.70
8,038.20
7,089.10
4,875.80
5,747.90
4,956.50
4,210.81
3,656.83
3,159.91
2,597.26
GP Margin
48.41%
48.55%
48.39%
48.35%
46.17%
51.11%
51.54%
51.08%
50.40%
50.85%
50.16%
Total Expenditure
17,724.60
16,668.50
14,562.90
12,477.50
9,426.90
9,665.80
8,554.70
7,452.09
6,548.95
5,534.38
4,443.78
Power & Fuel Cost
-
247.20
217.50
193.70
169.70
213.00
183.80
166.68
127.89
122.80
93.98
% Of Sales
-
1.30%
1.31%
1.32%
1.61%
1.89%
1.91%
2.02%
1.76%
1.98%
1.81%
Employee Cost
-
2,493.70
2,176.70
1,786.50
1,601.00
1,852.90
1,598.20
1,404.39
1,196.50
1,023.55
860.02
% Of Sales
-
13.08%
13.10%
12.18%
15.16%
16.47%
16.62%
17.04%
16.49%
16.47%
16.61%
Manufacturing Exp.
-
2,290.90
1,981.00
1,800.80
492.60
504.30
419.80
433.58
414.16
387.28
296.08
% Of Sales
-
12.02%
11.92%
12.28%
4.66%
4.48%
4.37%
5.26%
5.71%
6.23%
5.72%
General & Admin Exp.
-
1,707.10
1,494.40
1,009.10
1,253.80
1,366.30
1,551.20
1,291.65
1,116.65
868.33
563.51
% Of Sales
-
8.96%
9.00%
6.88%
11.87%
12.15%
16.13%
15.67%
15.39%
13.97%
10.88%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
124.10
119.00
113.90
225.60
230.40
140.80
123.13
94.88
77.67
0.00
% Of Sales
-
0.65%
0.72%
0.78%
2.14%
2.05%
1.46%
1.49%
1.31%
1.25%
0.95%
EBITDA
2,744.80
2,390.70
2,049.60
2,185.10
1,133.10
1,581.00
1,062.70
791.38
706.75
680.27
734.67
EBITDA Margin
13.41%
12.54%
12.34%
14.90%
10.73%
14.06%
11.05%
9.60%
9.74%
10.95%
14.19%
Other Income
131.30
106.30
90.30
78.20
49.10
33.20
32.40
33.95
44.33
52.54
36.75
Interest
465.80
449.40
380.80
378.60
449.20
532.80
327.00
295.07
257.35
180.02
117.85
Depreciation
718.60
687.00
615.40
600.70
573.10
619.70
395.50
359.03
314.04
263.83
211.65
PBT
1,691.70
1,360.60
1,143.70
1,284.00
159.90
461.70
372.60
171.24
179.69
288.95
441.92
Tax
494.90
445.50
256.20
477.00
84.70
225.10
173.40
111.91
90.96
96.90
130.00
Tax Rate
29.25%
32.70%
22.40%
30.23%
38.38%
34.11%
46.54%
65.35%
50.62%
31.78%
28.55%
PAT
1,196.80
880.60
862.30
1,048.30
149.60
458.00
235.00
117.19
178.60
209.14
330.55
PAT before Minority Interest
1,155.90
917.00
887.50
1,101.10
136.00
434.90
199.20
59.33
88.73
207.99
325.41
Minority Interest
-40.90
-36.40
-25.20
-52.80
13.60
23.10
35.80
57.86
89.87
1.15
5.14
PAT Margin
5.85%
4.62%
5.19%
7.15%
1.42%
4.07%
2.44%
1.42%
2.46%
3.37%
6.38%
PAT Growth
61.71%
2.12%
-17.74%
600.74%
-67.34%
94.89%
100.53%
-34.38%
-14.60%
-36.73%
 
EPS
83.23
61.24
59.97
72.90
10.40
31.85
16.34
8.15
12.42
14.54
22.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
6,935.40
6,197.40
5,623.30
4,602.50
3,339.10
3,333.50
3,251.51
3,313.20
3,331.13
3,171.33
Share Capital
71.90
71.90
71.90
71.90
69.60
69.60
69.56
73.01
69.56
69.56
Total Reserves
6,691.10
6,040.60
5,542.50
4,524.30
3,266.50
3,261.10
3,180.05
3,238.91
3,260.64
3,100.63
Non-Current Liabilities
6,808.90
6,225.50
6,242.00
5,590.10
6,482.70
4,613.00
4,423.17
4,398.65
2,700.91
2,138.49
Secured Loans
2,231.40
1,923.70
2,408.20
2,466.00
2,852.00
2,868.70
2,728.43
2,477.64
2,303.08
1,563.22
Unsecured Loans
4.20
13.90
19.00
7.40
0.00
83.40
195.37
475.74
146.70
164.83
Long Term Provisions
2,124.90
1,723.40
1,341.60
1,061.00
1,011.20
883.00
784.96
701.39
3.27
3.45
Current Liabilities
4,664.50
3,324.90
2,434.30
2,038.00
2,337.30
1,955.40
1,567.23
963.36
1,249.83
1,076.33
Trade Payables
2,368.60
1,915.60
1,631.80
1,160.00
908.80
713.10
606.02
501.19
550.19
419.14
Other Current Liabilities
1,425.90
684.80
472.10
382.40
807.80
640.80
501.70
295.59
446.16
439.91
Short Term Borrowings
725.30
609.10
208.50
385.90
497.50
498.20
379.17
70.69
182.93
85.74
Short Term Provisions
144.70
115.40
121.90
109.70
123.20
103.30
80.33
95.89
70.55
131.54
Total Liabilities
18,793.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80
6,459.16
Net Block
9,660.50
8,515.70
8,290.90
6,773.00
7,426.20
4,975.10
4,765.71
4,583.29
3,997.42
3,244.12
Gross Block
14,193.30
12,473.20
11,717.50
9,612.40
10,222.00
6,599.50
6,023.63
5,499.02
4,609.14
4,285.44
Accumulated Depreciation
4,532.80
3,957.50
3,426.60
2,839.40
2,795.80
1,624.40
1,257.92
915.73
611.73
1,041.32
Non Current Assets
13,514.20
11,744.70
10,518.70
8,789.00
9,643.00
7,755.60
7,154.22
6,670.57
5,385.23
4,520.29
Capital Work in Progress
872.80
609.90
45.50
233.90
235.60
821.80
712.20
346.86
561.56
532.64
Non Current Investment
302.10
281.40
314.80
350.20
365.10
399.30
301.26
307.96
270.65
165.08
Long Term Loans & Adv.
2,608.90
2,178.80
1,769.30
1,421.30
1,598.40
1,431.60
1,254.62
1,325.53
498.28
578.45
Other Non Current Assets
66.50
154.80
93.50
10.60
17.70
127.80
120.43
106.93
57.33
0.00
Current Assets
5,279.70
4,337.00
4,060.60
3,641.50
2,646.80
2,281.80
2,220.13
2,129.22
1,974.57
1,938.88
Current Investments
684.00
292.20
501.30
997.80
74.90
68.80
57.87
105.84
81.73
145.57
Inventories
459.80
390.10
431.90
249.50
737.80
584.70
565.84
466.87
406.13
350.26
Sundry Debtors
2,514.90
2,234.20
1,764.70
1,331.10
1,027.20
1,023.20
825.19
750.53
609.37
609.27
Cash & Bank
933.80
775.80
924.00
724.40
466.80
346.90
417.25
524.50
378.79
377.33
Other Current Assets
687.20
226.40
141.00
144.80
340.10
258.20
353.97
281.47
498.55
456.43
Short Term Loans & Adv.
429.00
418.30
297.70
193.90
96.70
79.40
112.29
223.03
437.25
419.99
Net Current Assets
615.20
1,012.10
1,626.30
1,603.50
309.50
326.40
652.90
1,165.86
724.74
862.55
Total Assets
18,793.90
16,081.70
14,579.30
12,430.50
12,289.80
10,037.40
9,374.35
8,799.79
7,359.80
6,459.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
1,920.20
1,376.90
1,696.00
1,264.50
1,292.90
905.20
536.96
622.55
597.17
469.95
PBT
1,380.50
1,100.50
1,578.10
221.50
656.90
373.60
59.56
131.12
305.25
455.41
Adjustment
1,199.20
1,108.40
681.40
1,079.80
1,012.50
770.10
807.85
703.53
425.00
274.83
Changes in Working Capital
-192.80
-450.00
-359.20
-72.10
-70.40
-46.00
-205.35
-78.48
10.82
-160.83
Cash after chg. in Working capital
2,386.90
1,758.90
1,900.30
1,229.20
1,599.00
1,097.70
662.06
756.17
741.07
569.42
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-466.70
-382.00
-204.30
35.30
-306.10
-192.50
-125.10
-133.62
-141.19
-100.28
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.71
0.81
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,537.20
-870.60
-847.20
-863.40
-288.80
-710.60
-404.91
-1,151.88
-888.21
-759.07
Net Fixed Assets
-1,399.90
-324.10
-166.80
1,127.70
-2,378.60
-622.09
-796.57
-582.72
-278.38
-570.07
Net Investments
-404.00
-158.10
31.60
-1,014.40
9.00
-185.02
163.48
-186.58
-164.16
-22.99
Others
266.70
-388.40
-712.00
-976.70
2,080.80
96.51
228.18
-382.58
-445.67
-166.01
Cash from Financing Activity
-311.10
-633.00
-791.60
-340.10
-909.60
-214.70
-108.50
476.95
329.93
392.31
Net Cash Inflow / Outflow
71.90
-126.70
57.20
61.00
94.50
-20.10
23.55
-52.37
38.89
103.19
Opening Cash & Equivalents
433.50
546.30
388.70
380.70
286.20
306.30
282.78
335.15
339.90
274.15
Closing Cash & Equivalent
505.50
433.40
546.50
425.20
380.70
286.20
306.33
282.78
378.79
377.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
469.76
424.53
389.89
319.08
239.10
238.71
233.02
237.25
238.81
227.87
ROA
5.26%
5.79%
8.15%
1.10%
3.90%
2.05%
0.65%
1.10%
3.01%
5.51%
ROE
14.26%
15.16%
21.60%
3.44%
13.08%
6.07%
1.81%
2.68%
6.41%
10.59%
ROCE
19.08%
17.78%
24.92%
9.32%
17.13%
10.24%
7.12%
6.94%
8.57%
12.09%
Fixed Asset Turnover
1.43
1.37
1.37
1.06
1.34
1.52
1.43
1.44
1.40
1.32
Receivable days
45.47
43.93
38.53
40.76
33.27
35.08
34.88
34.21
35.79
39.79
Inventory Days
8.14
9.03
8.48
17.06
21.46
21.83
22.86
21.96
22.21
22.16
Payable days
79.74
75.50
67.27
66.42
34.00
33.10
31.52
33.88
36.38
31.48
Cash Conversion Cycle
-26.12
-22.54
-20.26
-8.60
20.73
23.81
26.22
22.28
21.62
30.47
Total Debt/Equity
0.47
0.44
0.47
0.62
1.08
1.10
1.06
0.95
0.85
0.63
Interest Cover
4.03
4.00
5.17
1.49
2.24
2.14
1.58
1.70
2.69
4.86

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Apollo Hospitals Enterprise reports 59% rise in Q2 consolidated net profit
    6th Nov 2024, 17:17 PM

    Total consolidated income of the company increased by 15.58% at Rs 5627.50 crore for Q2FY25

    Read More
  • Apollo Hospitals to build 500-bed hospital in Mumbai
    4th Nov 2024, 10:13 AM

    With these 2 additions, Apollo Hospitals now has plans to add over 3512 capacity beds (2877 census/ operational beds) over the next 4 years across 11 locations in India

    Read More
  • Apollo Hospitals Enterprise’s arm incorporates wholly owned subsidiary
    4th Sep 2024, 17:43 PM

    Consequent to the incorporation of Apollo 24/7 Insurance Services, it became a Wholly Owned Step-Down Subsidiary of the company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.